Breast Cancer Genome Guided Therapy Study (BEAUTY)

The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors.

Choline C-11: Pulling back the curtain on prostate cancer

Mayo Clinic has integrated production, imaging and pathology facilities to provide the benefit of Choline C 11 PET imaging to prostate cancer patients.

Viral Hepatitis Among Somali Immigrants in MN: Association of Hepatitis C

Dr. Abdirashid Shire, Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester, MN, discusses his article appearing in the January 2012 issue of Mayo Clinic Proceedings.

The increasing incidence of young-onset colorectal cancer: A call to action

Dr. Whitney Jones from the University of Kentucky in Louisville, and Jasmine Greenamyer from the Colon Cancer Alliance in Washington, D.C., discuss the article appearing in the February 2014 issue of Mayo Clinic Proceedings.

The high cost of cancer drugs and what we can do about it

S. Vincent Rajkumar, M.D., a hematologist from Mayo Clinic in Rochester, Minnesota, discusses his article appearing in the October 2012 issue of Mayo Clinic Proceedings, where he explains the reasons behind the high cost of cancer treatments in the U.S.

Residential and outpatient treatment comparison for tobacco dependence

J. Taylor Hays, M.D., associate professor of medicine at Mayo Clinic in Rochester, Minnesota, discusses his article appearing in the March 2011 issue of Mayo Clinic Proceedings.

Population Screening for Barrett's Esophagus

Dr. Ganapathy A. Prasad, Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester, MN, discusses his article appearing in the December 2011 issue of Mayo Clinic Proceedings.

Nonclonal serum immunoglobulin free light chains to predict overall survival

S. Vincent Rajkumar, M.D., reviews his Olmsted County population-based study investigating the detection of high polyclonal free light chain levels as a predictor of mortality outcomes across multiple conditions.

Monoclonal gammopathy-associated proliferative glomerulonephritis — S. Vincent Rajkumar, M.D.

S. Vincent Rajkumar, M.D., in the Department of Hematology at Mayo Clinic, introduces and explains the importance of recognizing monoclonal gammopathies as a major cause of proliferative glomerulonephritis.

Monoclonal gammopathy-associated proliferative glomerulonephritis — Sanjeev Sethi, M.D., Ph.D.

Sanjeev Sethi, M.D., Ph.D., a professor of laboratory medicine and pathology at Mayo Clinic, presents findings that define the role of monoclonal proteins in proliferative glomerulonephritis and propose evaluation and new treatment algorithms ...

Metabolic Syndrome as a Risk Factor for Barrett's Esophagus

Noting a 2-fold increase in risk of Barrett's Esophagus, Dr. Cadman Leggett, a fellow in gastroenterology at Mayo Clinic in Rochester, MN, discusses his article appearing in the February 2013 issue of Mayo Clinic Proceedings.

Melanoma in immunosuppressed patients

Jerry D. Brewer, M.D., M.S., a dermatologic surgeon from the Department of Dermatology at Mayo Clinic in Rochester, Minnesota, unmasks a previously unknown higher risk of melanoma in immunosuppressed and transplant patients.